Unknown

Dataset Information

0

Identification of Novel Vacuolin-1 Analogues as Autophagy Inhibitors by Virtual Drug Screening and Chemical Synthesis.


ABSTRACT: Autophagy is a fundamental cellular degradation process which is essential for cell homeostasis, and dysfunctional autophagy has been associated with a variety of human diseases, such as cancer. Several autophagy chemical modulators have been applied in a number of preclinical or clinical trials against these autophagy related diseases, especially cancer. Small molecule vacuolin-1 potently and reversibly inhibits both endosomal-lysosomal trafficking and autophagosome-lysosome fusion, yet the molecular mechanisms underlying vacuolin-1 mediated autophagy inhibition remain unknown. Here, we first performed the virtual drug screening and identified 14 vacuolin-1 analogues as autophagy inhibitors. Based on these virtual screening results, we further designed and synthesized 17 vacuolin-1 analogues, and found that 13 of them are autophagy inhibitors and a couple of them are as potent as vacuolin-1. In summary, these studies expanded the pool of useful autophagy inhibitors and reveal the structural-activity relationship of vacuolin-1 analogues, which is useful for future development of vacuolin-1 analogues with high potency and for identification of the molecular targets of vacuolin-1.

SUBMITTER: Chen C 

PROVIDER: S-EPMC6152680 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Identification of Novel Vacuolin-1 Analogues as Autophagy Inhibitors by Virtual Drug Screening and Chemical Synthesis.

Chen Chang C   Lu Yingying Y   Siu Ho Ming HM   Guan Jintao J   Zhu LongChao L   Zhang Shuang S   Yue Jianbo J   Zhang Liangren L  

Molecules (Basel, Switzerland) 20170527 6


Autophagy is a fundamental cellular degradation process which is essential for cell homeostasis, and dysfunctional autophagy has been associated with a variety of human diseases, such as cancer. Several autophagy chemical modulators have been applied in a number of preclinical or clinical trials against these autophagy related diseases, especially cancer. Small molecule vacuolin-1 potently and reversibly inhibits both endosomal-lysosomal trafficking and autophagosome-lysosome fusion, yet the mol  ...[more]

Similar Datasets

| S-EPMC7119052 | biostudies-literature
| S-EPMC2637080 | biostudies-literature
| S-EPMC2659327 | biostudies-other
| S-EPMC8347235 | biostudies-literature
| S-EPMC6861579 | biostudies-literature
| S-EPMC3627673 | biostudies-literature
| S-EPMC10964497 | biostudies-literature
| S-EPMC7986591 | biostudies-literature
| S-EPMC10688023 | biostudies-literature
| S-EPMC9395932 | biostudies-literature